Navigation Links
AACC Cautions FDA Against Over-regulating the Genetic Testing Technology Vital to Precision Medicine
Date:3/16/2015

WASHINGTON, March 16, 2015 /PRNewswire-USNewswire/ -- Today AACC sent formal comments to the Food and Drug Administration (FDA) on the agency's proposed regulation of next-generation sequencing tests. AACC appreciates FDA's efforts to seek input from the healthcare community before developing new policy in this area, but is concerned that FDA regulation of next-generation sequencing could impede the advancement of precision medicine. 

Precision medicine uses a person's unique biological makeup, including genetics, to determine which treatments that person would respond to best. Genetic tests hold the potential to predict an individual's risk of developing numerous different conditions throughout life. Having this knowledge could lead one to take a more proactive approach to his or her health, particularly with respect to chronic diseases such as cardiovascular disease and diabetes that could be prevented with basic lifestyle changes. Next-generation sequencing will enhance the application of precision medicine by making genetic testing more readily available.

After reviewing FDA's preliminary discussion paper on the topic, "Optimizing FDA's Regulatory Oversight of Next-Generation Sequencing Diagnostic Tests," AACC recommends that oversight of next-generation sequencing remain under the Clinical Laboratory Improvement Amendments (CLIA) like other laboratory developed tests. CLIA-regulated laboratories conducting next-generation sequencing testing are experienced in developing, verifying, and performing clinical tests. AACC believes that CLIA-recognized accrediting bodies and professional societies should continue to take the lead in providing oversight and guidance for next-generation sequencing testing in the absence of specific, identified problems with this approach.  

"AACC agrees with the FDA that next-generation sequencing tests offer great opportunities for advancing laboratory medicine and improving patient care, and we commend the agency's efforts to initiate a dialogue among the various organizations and professionals involved in next-generation sequencing and those affected by such testing," said AACC President Dr. David D. Koch. "We believe, however, that the current oversight mechanisms in place for next-generation sequencing are sufficient for dealing with the particular challenges this technology presents and that further FDA involvement at this time might hinder the advancement of this field." 

Read AACC's comment letter here

About AACC 
Dedicated to achieving better health through laboratory medicine, AACC brings together more than 50,000 clinical laboratory professionals, physicians, research scientists, and business leaders from around the world focused on clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine, lab management, and other areas of breaking laboratory science. Since 1948, AACC has worked to advance the common interests of the field, providing programs that advance scientific collaboration, knowledge, expertise, and innovation. For more information, visit www.aacc.org

Molly Polen
AACC
Director of Communications & PR
(p) 202.420.7612
(c) 703.598.0472
mpolen@aacc.org

Logo - http://photos.prnewswire.com/prnh/20130701/PH41045LOGO


'/>"/>
SOURCE AACC
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Organovo Cautions Investors in Regards to "Short and Distort" Articles
2. Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases
3. Halozymes Phase 1b Clinical Trial Of PEGPH20 With Gemcitabine Indicates Positive Activity Against Pancreatic Cancer
4. ResMed Takes Action to Enforce Patents Against BMC and 3B
5. Bernstein Liebhard LLP Announces That A Class Action Has Been Filed Against Invacare Corporation
6. Bernstein Liebhard LLP Announces That a Class Action Has Been Filed Against Intuitive Surgical, Inc.
7. Royalty Pharma Urges Elan Shareholders to Vote AGAINST ALL FOUR Elan Resolutions Today
8. PDL Files for Arbitration Against Genentech Based on Underpayment of Royalties
9. Consumer Watchdog: United Healthcare Sued for Discriminating Against HIV/AIDS Patients
10. The World Customs Organization (WCO) and the Institute of Research Against Counterfeit Medicines (IRACM) issue a new warning about the health and safety of African populations
11. Elan ADS Holders Decisively Vote Against Theravance And AOP Transactions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2020)... ... August 26, 2020 , ... ... Testing division, expands its technology footprint with the addition of Novocyte Quanteon™ ... With industry-leading biomarker solutions, complemented with traditional ligand-binding assays and study management ...
(Date:8/26/2020)... ... August 26, 2020 , ... As the U.S. struggles in its ... for preventing the Coronavirus. Wear a mask, keep your distance, wash your hands. Prevention ... Burkitt said it best in 1977, “How much better it is to prevent disease ...
(Date:8/26/2020)... ... 26, 2020 , ... The Lymphoma Research Foundation (LRF) ... and serving the lymphoma community through education programs, outreach initiatives and patient services ... and Charity Auction on Wednesday, Sept. 30 . The “Finding Cures Starts ...
Breaking Medicine Technology:
(Date:8/31/2020)... ... August 31, 2020 , ... Ocean Springs, Mississippi-based pharmaceutical ... medical first responders across the United States. Since the start of the global ... (PPE) medical centers , hospitals , firefighters , and ...
(Date:8/31/2020)... ... ... pandemic and topsy-turvy economic outlook continues to put financial strain on many of us, so ... fat from our monthly expenses and put more into savings, if possible. , “That’s a ... financial safety net in place in case something were to happen to you,” says Lee ...
(Date:8/29/2020)... MONTREAL (PRWEB) , ... August 29, 2020 , ... When ... - perhaps with greater ease than most people would. Rather than become melancholic, however, ... yet deep advice on achieving one’s dreams. Randy Pausch took a negative situation and ...
(Date:8/28/2020)... ... ... Integrated Viral Protection (IVP Air) today announced that the True North Classical ... Indoor Air Protection System that is the first system designed and proven to catch ... the filtration system on September 8th. , The IVP Air S1 model is ...
(Date:8/27/2020)... ... August 27, 2020 , ... ... Evolution Labs to provide their students with Suite360:Mental Health and Prevention, a program ... Substance Abuse and Child Trafficking Prevention. , Florida schools and districts must provide ...
Breaking Medicine News(10 mins):